# Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme

> **NCT00006386** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 80 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** carmustine
- **RADIATION:** radiation therapy
- **RADIATION:** stereotactic radiosurgery

## Key facts

- **NCT ID:** NCT00006386
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2004-11
- **Final completion:** 2009-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006386, "Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00006386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*